| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 08/19/1997 | US5658896 Water-soluble silicate polymer |
| 08/19/1997 | US5658786 DNA encoding rat taurine transporter and uses thereof |
| 08/19/1997 | US5658767 Plant extract; vegetable oil; infant's formula |
| 08/19/1997 | US5658590 Treatment of attention-deficit/hyperactivity disorder |
| 08/19/1997 | CA1339314C Antipsychotic 4-¬4-(3-benzisothiazolyl)-1-piperazinyl|butyl bridged bicyclic imides |
| 08/17/1997 | CA2197611A1 Pseudopeptides derives from neurokinins and their preparation process |
| 08/14/1997 | WO1997029131A1 HUMAN ANTIBODIES THAT BIND HUMAN TNF$g(a) |
| 08/14/1997 | WO1997029110A1 Thiophenopyrimidines |
| 08/14/1997 | WO1997029109A1 Pyrazolopyrimidines as crf receptor antagonists |
| 08/14/1997 | WO1997029101A1 Novel cyclic amino acids as pharmaceutical agents |
| 08/14/1997 | WO1997028796A1 Biologically active ureido derivatives useful in the treatment of multiple sclerosis |
| 08/14/1997 | WO1997028791A1 Use of deprenyl compounds to maintain, prevent loss, or recover nerve cell function |
| 08/14/1997 | WO1997013489A3 Stable extract of hypericum perforatum l., process for preparing the same and pharmaceutical compositions |
| 08/14/1997 | CA2245836A1 Use of deprenyl compounds to maintain, prevent loss, or recover nerve cell function |
| 08/14/1997 | CA2244708A1 Novel cyclic amino acids as pharmaceutical agents |
| 08/14/1997 | CA2233307A1 Thiophenopyrimidines |
| 08/14/1997 | CA2217008A1 Biologically active ureido derivatives useful in the treatment of multiple sclerosis |
| 08/13/1997 | EP0789077A1 Viral material and nucleotide fragments associated with multiple sclerose having diagnostic, prophylactic and therapeutical uses |
| 08/13/1997 | EP0789021A1 Hydroxamic acid compounds as opioid kappa receptor agonists |
| 08/13/1997 | EP0788795A1 Pharmacologically active 2-mercaptobenzimidazole derivatives |
| 08/13/1997 | EP0788543A1 Alk-7 (activin like kinase), a serine threonine kinase receptor |
| 08/13/1997 | EP0788514A1 Binding agents for treatment of inflammatory, autoimmune or allergic diseases |
| 08/13/1997 | EP0788513A1 Binding agents to cd23 |
| 08/13/1997 | EP0788509A1 Therapeutic peptide derivatives |
| 08/13/1997 | EP0788503A1 Novel quinoxalindione derivatives, their production and use in medicaments |
| 08/13/1997 | EP0788501A1 Protein kinase inhibitors for treatment of neurological disorders |
| 08/13/1997 | EP0788499A1 Cns-active pyridinylurea derivatives |
| 08/13/1997 | EP0788497A1 Bisarylcarbinol derivatives as inhibitors of leukotriene biosynthesis |
| 08/13/1997 | EP0788491A1 6-polyfluoroalkoxy and 6-polyfluoroalkyl-2-aminobenzothiazole derivatives |
| 08/13/1997 | EP0788489A1 Heterocyclic compounds and their use |
| 08/13/1997 | EP0788478A1 Azetidinone derivatives for the treatment of atherosclerosis |
| 08/13/1997 | EP0788371A1 Analgesic method with dynorphin analogues truncated at the n-terminus |
| 08/13/1997 | EP0788366A1 Use of 2'-substituted oligonucleotides to down-regulating gene expression |
| 08/13/1997 | EP0788359A1 Compositions useful for the preparation of medicines for treating a variety of intractable disorders |
| 08/13/1997 | EP0788357A1 A method of treating urinary bladder dysfunctions |
| 08/13/1997 | EP0788349A1 Liposome composition containing selegilin |
| 08/13/1997 | EP0691958B1 (s)-alpha-phenyl-2-pyridineethanamine benzoate and its use as a medicament |
| 08/13/1997 | EP0691957B1 (s)-alpha-phenyl-2-pyridineethanamine (s)-malate and its use as a medicament |
| 08/13/1997 | EP0583485B1 Ethanolamine derivatives having sympathomimetic and anti-pollakiuria activities |
| 08/13/1997 | EP0532553B1 Use of compounds for the treatment of age-related memory impairment and other cognitive disorders |
| 08/13/1997 | EP0486666B1 Therapeutic heterocyclic compounds |
| 08/13/1997 | CN1156993A Dihydrobenzofuran and related compounds useful as anti-inflammatory agents |
| 08/13/1997 | CN1156989A N-Substituted azabicycloheptane derivatives and preparing process and use thereof |
| 08/13/1997 | CN1156962A Cosolvent parenteral formulation of tirilazad |
| 08/13/1997 | CN1156961A Formulations and method for providing prolonged local anesthesia |
| 08/13/1997 | CN1156606A Chinese medicine pill for treating paralysis |
| 08/13/1997 | CN1035615C Process for preparing heteroaryl amines as acetylcholinesterase |
| 08/12/1997 | US5656669 Restorative neuropharmacological agent for motor and speech disturbance |
| 08/12/1997 | US5656667 Fatty acid composition |
| 08/12/1997 | US5656658 Administering an amino chroman derivative |
| 08/12/1997 | US5656657 Chroman derivatives |
| 08/12/1997 | US5656648 Treatment of pathologies necessitating stimulation of cholecystokinin-a receptors by total or partial agonist effect |
| 08/12/1997 | US5656639 Heterocyclic compounds, method of preparing them and pharmaceutical compositions in which they are present |
| 08/12/1997 | US5656633 Carbostyril derivatives and pharmaceutical compositions containing the same for use as a disturbance-of-consciousness improving agent, central nervous system stimulant or sigma receptor agonist |
| 08/12/1997 | US5656627 Inhibitors of interleukin-1β converting enzyme |
| 08/12/1997 | US5656626 Nervous system or brain disorders; benz(b)azepine |
| 08/12/1997 | US5656481 Compositions and methods for the delivery of biologically active molecules using cells contained in biocompatible capsules |
| 08/12/1997 | US5656255 Composition to help stop smoking |
| 08/07/1997 | WO1997028191A1 Mhc complexes and uses thereof |
| 08/07/1997 | WO1997028189A1 Methods for increasing endogenous levels of corticotropin-releasing factor |
| 08/07/1997 | WO1997028184A1 Method of treating beta-amyloid peptide associated conditions using trh |
| 08/07/1997 | WO1997028178A1 High affinity nucleic acid ligands of complement system proteins |
| 08/07/1997 | WO1997028163A1 Condensed 2,3-benzodiazepine derivatives and their use as ampa-receptor inhibitors |
| 08/07/1997 | WO1997028162A1 Diazabicyclo-octane derivatives as 5-ht receptor ligands |
| 08/07/1997 | WO1997028160A1 Endothelin receptor antagonists |
| 08/07/1997 | WO1997028159A1 Endothelin receptor antagonists |
| 08/07/1997 | WO1997028158A1 Endothelin receptor antagonists |
| 08/07/1997 | WO1997028155A1 Dihydrobenzofuran and related compounds useful as anti-inflammatory agents |
| 08/07/1997 | WO1997028154A1 Endothelin receptor antagonists |
| 08/07/1997 | WO1997028147A1 Dihydrobenzofuran and related compounds useful as anti-inflammatory agents |
| 08/07/1997 | WO1997028145A1 Dihydrobenzofuran and related compounds useful as anti-inflammatory agents |
| 08/07/1997 | WO1997028141A1 Novel aromatic piperazines derived from substituted cycloazanes, method for preparing same, pharmaceutical compositions, and use thereof as drugs |
| 08/07/1997 | WO1997028140A1 NOVEL PIPERIDINES DERIVED FROM 1-/(PIPERAZIN-1-YL)ARYL(OXY/AMINO)CARBONYL/-4-ARYL-PIPERIDINE AS SELECTIVE 5-HT1Db RECEPTOR ANTAGONISTS |
| 08/07/1997 | WO1997028135A1 2,3-benzodiazepine derivatives and their use as ampa-receptor inhibitors |
| 08/07/1997 | WO1997028129A1 Aminoheterocyclic derivatives as antithrombotic or anticoagulant agents |
| 08/07/1997 | DE19604920A1 Neue 2,3-Benzodiazepinderivate, deren Herstellung und Verwendung als Arzneimittel New 2,3-benzodiazepine derivatives, their preparation and use as medicaments |
| 08/07/1997 | DE19604919A1 Neue 2,3-Benzodiazepinderivate, deren Herstellung und Verwendung als Arzneimittel New 2,3-benzodiazepine derivatives, their preparation and use as medicaments |
| 08/07/1997 | CA2630098A1 High affinity nucleic acid ligands of complement system proteins |
| 08/07/1997 | CA2245145A1 Method of treating beta-amyloid peptide associated conditions using trh |
| 08/07/1997 | CA2244940A1 Novel piperidines derived from 1-/(piperazin-1-yl)aryl(oxy/amino)carbonyl/-4-aryl-piperidine as selective 5-ht1db receptor antagonists |
| 08/07/1997 | CA2244755A1 Mhc complexes and uses thereof |
| 08/07/1997 | CA2244203A1 Dihydrobenzofuran and related compounds useful as anti-inflammatory agents |
| 08/07/1997 | CA2244199A1 Dihydrobenzofuran and related compounds useful as anti-inflammatory agents |
| 08/06/1997 | EP0787797A1 Human 5-HT1D receptor (serotonin receptor), process for preparing the same, its uses, antibodies directed against this receptor and transgenics expressing it |
| 08/06/1997 | EP0787729A2 A process for the manufacture of imidazodiazepine derivatives |
| 08/06/1997 | EP0787724A1 Novel intermediate for production and process for producing pyridine derivative |
| 08/06/1997 | EP0787723A1 Cyclopropachromenecarboxylate derivatives |
| 08/06/1997 | EP0787715A1 Process for the optical resolution of tramadol |
| 08/06/1997 | EP0787489A2 Composition containing L-carnitine or alkanoyl-L-carnitine and hydroxycitric acid or pantothenic acid |
| 08/06/1997 | EP0787206A1 USE OF NEURITE LOCALIZED mRNAs FOR MEDICAL DIAGNOSIS AND THERAPEUTICS |
| 08/06/1997 | EP0787197A1 Immortalized lines of endothelial brain cells and therapeutical applications thereof |
| 08/06/1997 | EP0787148A1 Al-1 neurotrophic factor, a ligand for an eph-related tyrosine kinase receptor |
| 08/06/1997 | EP0787147A1 Compositions and treatment for multiple sclerosis |
| 08/06/1997 | EP0787142A1 Neurturin and related growth factors |
| 08/06/1997 | EP0787133A1 Tricyclic spiro compounds process for their preparation and their use as 5ht1d receptor antagonists |
| 08/06/1997 | EP0787131A1 Benzenesulphonamide derivatives as bradykinine antagonists |
| 08/06/1997 | EP0787130A1 Di-tert-butylphenol compounds with heterocyclic moiety, useful as anti-inflammatory agents |
| 08/06/1997 | EP0787013A1 Human hypoxanthine-(guanine) phosphoribosyl transferase-2 |
| 08/06/1997 | EP0786998A1 Use of r-(z)]-alpha-(methoxyimino)-alpha-(1-azabicyclo 2.2.2] oct-3-yl) acetonitrile to reduce amyloid beta a4 formation in alzheimer's disease |
| 08/06/1997 | EP0786995A1 Use of receptor potentiators |